Akademisyen
GÜLE ÇINAR
DOÇENT
ANKARA ÜNİVERSİTESİ TIP FAKÜLTESİ DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
- Ana Dal Sağlık Bilimleri Temel Alanı
- Yan Dal Enfeksiyon Hastalıkları ve Klinik Mikrobiyoloji
Kayıtlı çıktılara kısa bakış — ayrıntılar aşağıda.
- Makale 84
- Proje 0
- Kitap 0
- Bildiri 53
- Patent 0
- Sanatsal 0
Scopus (SJR)
Q1
21
Q2
13
Q3
10
Q4
22
WoS (JCR)
Q1
13
Q2
12
Q3
16
Q4
28
TR Index
28
makale
Alan+yıl+tür normalize OpenAlex yüzdelik — Clarivate ESI / SciVal değildir.
Üst %1 makale
3
Üst %10 makale
12
Ort. yüzdelik
56.1%
Üst %1 payı
4.2%
Üst %10 payı
16.9%
Makaleler
YÖKSİS ve OpenAlex kaynak ayrımıyla makaleler; quartile ve TR Index ile daraltabilirsiniz.
Makale listesi
- 2025 Evaluation of Treatment Response in Chronic Hepatitis C Patients Receiving Sofosbuvir/Velpatasvir/Voxilaprevir: A Multicenter Real-World Experience from Türkiye YÖKSİS SJR Q1 JCR Q2 OpenAlex 78.0%
- 2025 Epidemiology and Outcomes of Candida-Associated Osteoarticular Infections: A Multicenter Retrospective Study from Turkey YÖKSİS SJR Q1 JCR Q1 OpenAlex 21.8%
- 2025 Key predictors of mortality in Crimean-Congo haemorrhagic fever: a retrospective multicentre cohort study YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 96.9%
- 2025 Key predictors of mortality in Crimean-Congo haemorrhagic fever: a retrospective multicentre cohort study YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 96.9%
- 2025 Evaluating the Prognostic Value of the EQUAL Candida Score and a Nomogram‐Based Approach for Candidaemia‐Related Mortality YÖKSİS SJR Q1 JCR Q2 OpenAlex 73.1%
- 2025 Fosfomycin-based combinations against carbapenemase-producing Klebsiella pneumoniae bloodstream infections: Correlating in vitro synergy with clinical outcomes YÖKSİS SJR Q1 JCR Q1 OpenAlex 21.2%
- 2025 Hashimoto’s encephalopathy in psychiatric inpatients: neuropsychiatric morbidity, diagnostic challenges and treatment YÖKSİS SJR Q1 JCR Q2 OpenAlex 72.5%
- 2025 The aetiologic agents and resistance rates in community-acquired complicated intra-abdominal infections: Where are we locally? YÖKSİS SJR Q2 JCR Q3 OpenAlex 23.6%
- 2025 Retrospective chart review of cases of steroid-responsive catatonia: exploring a potential autoimmune aetiology YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 91.8%
- 2025 Factors associated with fibrotic-like pattern on thorax CT after COVID-19 pneumonia YÖKSİS TR Index SJR Q3 JCR Q4 OpenAlex 7.2%
- 2025 Ceftazidime-Avibactam: A Retrospective Analysis of Multicenter Real-World Data and Factors Affecting Mortality YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 41.2%
- 2025 Candida auris vs. Non-Candida auris Candidemia in Critically Ill Patients: Clinical Outcomes, Risk Factors, and Mortality YÖKSİS SJR Q1 JCR Q1 OpenAlex üst %10 OpenAlex 98.2%
- 2024 Cytomegalovirus Infections in Patients Diagnosed with Inflammatory Bowel Disease YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 30.3%
- 2024 The Efficacy of Glecaprevir/Pibrentasvir in Chronic Hepatitis C Patients and the Impact of the COVID-19 Pandemic: Multicenter Real-Life Data YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 54.6%
- 2023 Waning immunity to inactive SARS-CoV-2 vaccine in healthcare workers: booster required YÖKSİS SJR Q2 JCR Q2 OpenAlex 89.0%
- 2023 Dark Side of the COVID-19 Pandemic; ‘Long COVID’ YÖKSİS TR Index SJR Q4 JCR Q4 OpenAlex 64.8%
- 2023 BNT162b2 or CoronaVac as the Third Dose against Omicron: Neutralizing Antibody Responses among Transplant Recipients Who Had Received Two Doses of CoronaVac YÖKSİS SJR Q1 JCR Q2 OpenAlex 66.4%
- 2022 Factors associated with progression of depression, anxiety, and stress‐related symptoms in outpatients and inpatients with COVID‐19: A longitudinal study YÖKSİS SJR Q2 JCR Q3 OpenAlex 78.9%
- 2022 Characteristics and outcomes of carbapenemase harbouring carbapenem-resistant Klebsiella spp. bloodstream infections: a multicentre prospective cohort study in an OXA-48 endemic setting YÖKSİS SJR Q1 JCR Q2 OpenAlex üst %10 OpenAlex 91.8%
- 2022 Cytomegalovirus infection in patients with glomerular diseases treated with cyclophosphamide: a single-center prospective study YÖKSİS SJR Q2 JCR Q3 OpenAlex 56.8%